Women's Estrogen for Stroke Trial (WEST)
NCT00026039 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2006-05-15
Summary
To determine if estrogen hormone replacement therapy reduces the risk of stroke or death in postmenopausal women who have already had stroke or a transient ischemic attack (TIA).
Conditions
Interventions
- DRUG
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
lead NIH
Principal Investigators
-
Ralph I. Horwitz, M.D. · Yale University
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1993-12-31
More Related Trials
-
Bioidentical 'Natural' Hormone Evaluation in Early Menopause
NCT00302731 ·Status: TERMINATED ·Phase: PHASE2
-
Impact of Estradiol on Endothelial Function in Peri-Menopausal Women
NCT04255160 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
NCT01942668 ·Status: COMPLETED ·Phase: PHASE3
-
Midlife Cholesterol Study
NCT00361075 ·Status: COMPLETED ·Phase: PHASE4
-
Estrogen Diastolic Heart Failure
NCT02693002 ·Status: TERMINATED ·Phase: PHASE4
-
Alzheimer's Disease: Therapeutic Potential of Estrogen
NCT00066157 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Aging and Estrogen on Cortical Function
NCT01268046 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
NCT00123539 ·Status: TERMINATED ·Phase: NA
-
Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
NCT00018343 ·Status: COMPLETED ·Phase: PHASE2
-
Hormone Replacement in Menopausal Women With Epilepsy
NCT00027209 ·Status: COMPLETED ·Phase: PHASE2
-
Alzheimer's Disease Prevention Trial
NCT00000176 ·Status: COMPLETED ·Phase: PHASE3
-
Perimenopausal Estrogen Replacement Therapy Study
NCT01308814 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women
NCT01633814 ·Status: TERMINATED ·Phase: NA
-
Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function
NCT03112226 ·Status: COMPLETED ·Phase: NA
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Vaginal and Urinary Microbiome Trial
NCT02869165 ·Status: COMPLETED ·Phase: PHASE4
-
Hormone Replacement Therapy and Prothrombotic Variants
NCT00049933 ·Status: COMPLETED
-
The Effects of Estrogen Withdrawal on Mood Symptoms in Women
NCT00060736 ·Status: COMPLETED
-
Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
NCT00002976 ·Status: TERMINATED ·Phase: PHASE3
-
The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs.
NCT03097120 ·Status: COMPLETED ·Phase: PHASE3
-
Postmenopausal Hormone Therapy in Unstable Angina
NCT00000601 ·Status: COMPLETED ·Phase: PHASE3
-
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
NCT02122198 ·Status: COMPLETED ·Phase: NA
-
A Pharmacokinetic Evaluation of Bioidentical Compounded Estrogen Cream and Natural Progesterone
NCT00864214 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy
NCT02691936 ·Status: COMPLETED ·Phase: NA
-
The Vaginal Health Trial
NCT02516202 ·Status: COMPLETED ·Phase: PHASE3